Prevention of allergic eye disease by treatment with IL-1 receptor antagonist

scientific article published on 01 November 1999

Prevention of allergic eye disease by treatment with IL-1 receptor antagonist is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10549671

P2093author name stringG Liu
S Ono
M R Dana
A M Keane-Myers
D Miyazaki
I Dekaris
P433issue12
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
P304page(s)3041-3046
P577publication date1999-11-01
P1433published inInvestigative Ophthalmology Visual ScienceQ6060707
P1476titlePrevention of allergic eye disease by treatment with IL-1 receptor antagonist
P478volume40

Reverse relations

cites work (P2860)
Q82485365A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva
Q41837279Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy
Q35221349Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma
Q24557550Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions
Q34529798New twists to an old story: novel concepts in the pathogenesis of allergic eye disease
Q38904210Ocular Manifestations of Inherited Phospholipase-Cγ2-Associated Antibody Deficiency and Immune Dysregulation
Q34730735Ocular allergy guidelines: a practical treatment algorithm
Q55299223Phage Therapy: Beyond Antibacterial Action.
Q47550004Phage therapy in allergic disorders?
Q37295510Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist
Q47094978The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy
Q34561837The pathogenesis of allergic conjunctivitis
Q34206399Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.
Q81606847[Ocular allergies]

Search more.